OncoLens Selected as a Venture Atlanta 2019 Presenting Company

ATLANTA, Sept. 16, 2019 /PRNewswire-PRWeb/ -- OncoLens announced today that it has been chosen out of hundreds of applicants as one of the top 36 rising star technology companies in the Southeast that will present on stage at Venture Atlanta 2019. The 12th annual Venture Atlanta, the Southeast's premier event for connecting technology innovation and investment capital, will be held October 16-17 in the heart of downtown Atlanta. With representation of over 150 national investor funds, an expected attendance of over 1,000 technology entrepreneurs, premier investors and key executives from across the country, Venture Atlanta has served as a launching pad for hundreds of companies over the past twelve years, connecting them with game-changing capital and opportunities to drive significant growth.

"We are thrilled to be coming back to Venture Atlanta this year as a presenting company. We were a showcase company last year and it is an honor to have been recognized for the traction we have built over the past year. We look forward to meeting industry experts, investors and fellow entrepreneurs at Venture Atlanta," said Anju Mathew, CEO of OncoLens.

OncoLens was chosen as one of 36 selected presenting companies from a large pool of applicants that represent the region's most innovative tech businesses.

OncoLens is a cloud-based SaaS (software as a service) platform that facilitates cancer care treatment planning by streamlining multi-disciplinary case collaboration among providers and providing clinical decision support, survivorship care planning, accreditation and quality improvement. This multi-disciplinary approach has shown increased positive outcomes for cancer patients. OncoLens automatically collects needed information in a platform which promotes collaboration, multi-disciplinary treatment planning, and clinical trial participation. Utilizing OncoLens services, clients have decreased their administrative time for treatment planning by up to 90% and were able to run additional cases through this multi-disciplinary approach. The use of OncoLens has been proven to improve the quality and time to treatment for cancer patients.

"Venture Atlanta has become the authority for recognizing technology innovation across the largest footprint in the Southeast, connecting the region's best and brightest innovators with top-tier investors and other leaders in our technology ecosystem that helps drive success and results with over $4.3 billion in funding awarded to date," said Allyson Eman, executive director of Venture Atlanta. "This year, with over one-third of the presenting companies coming from outside of Georgia, we're thrilled to be showcasing the largest line up yet of companies from emerging technologies to venture-stage companies. These companies reflect our region's incredible pool of talented people, inspiring innovation, and continued opportunities for growth within our technology community."

During the two-day event, presenting companies and conference attendees will engage with regional as well as national venture capitalists, investors, and other key players in the current technology landscape. The conference results in funding, national investor exposure, and invaluable relationship-building with successful technology executives. In addition to hearing from the 36 presenting companies and lineup of over a dozen expert speakers, attendees will have an opportunity to network with over 40 selected Venture Atlanta "startup showcase companies" to watch that represent the most exciting emerging technologies in the Southeast. These innovators will be highlighted with dedicated tables at the conference to provide sneak peeks into their plans and products. Atlanta- based independent investment management firm, Invesco, is this year's premier sponsor. Techstars will help kick off the conference on October 14 with Techstars Atlanta 2019 Demo Day in partnership with Cox Enterprises.

To learn more about OncoLens, visit http://www.OncoLens.com. For additional information about Venture Atlanta, to register for the event or to view the conference schedule, please visit http://www.ventureatlanta.org.

About Venture Atlanta
Venture Atlanta, the Southeast's technology innovation event, is where the region's most promising tech companies meet the country's top-tier investors. As the Southeast's largest investor showcase helping launch more than 350 companies and raise over $4.3 billion in funding to date, Venture Atlanta connects the region's top entrepreneurs with local and national venture capitalists, bankers, angel investors and others in the technology ecosystem who can help them raise the capital they need to grow their businesses. The annual nonprofit event is a collaboration of three leading Georgia business organizations: Atlanta CEO Council, Metro Atlanta Chamber and the Technology Association of Georgia (TAG). For more information, visit http://www.ventureatlanta.org. For updates, follow us on Twitter, and visit our blog.

About OncoLens
OncoLens develops technologies that improve cancer treatment planning, simplify Tumor Board management, facilitate survivorship care planning, and automate accreditation and quality reporting through an intelligent workflow engine that streamlines business processes and enables more informed clinical decision-making.

SOURCE OncoLens